Association of metabolic syndrome with complicated gall stone disease: our experience
DOI:
https://doi.org/10.18203/2349-2902.isj20192989Keywords:
Cholelithiasis, Gall stone, Metabolic syndromeAbstract
Background: Gall stone disease is the most common biliary pathology and frequently encountered in our daily practice. Patients with gall stone that experienced at least one attack of acute cholecystitis is defined as complicated gall stone disease (CGSD). Aim of this study was to find out the association between complicated gall stone disease and the metabolic syndrome.
Methods: This prospective, observational study was done from 1st March 2017 to 30th November 2018 in department of general surgery, SMS hospital Jaipur. All patients with cholelithiasis admitted in general surgery department were included. Metabolic syndrome was defined by adult treatment panel III (ATP III) criteria. All patients were divided in two groups: complicated gall stone disease (CGSD) and uncomplicated gall stone disease (UGSD).
Results: Mean age was 47.2 years in CGSD group and 46.7 year in UGSD group. Female to male ratio was 8.2:1 in CGSD group and 4:1 in UGSD. Metabolic syndrome was presented in 64 patients (58.2%) of CGSD group and 24 patients (21.8%) of UGSD patients, which was statistically significant (OR 4.986, CI 2.763-8.995, p value <0.001). Five components of metabolic syndrome were compared in both CGSD group and UGSD group. Lower serum HDL-C level and hyperglycemias was statistically significant in CGSD group as compared to UGSD group.
Conclusions: Metabolic syndrome can be use to predict complicated gall stone disease. Hyperglycaemia and lower HDL-C associated with CGSD. One should be aware about possible metabolic syndrome background when dealing with gall stone disease patients.
References
Bailey and love’s short practise of surgery text book 27th edition: 1198.
Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med. 1978;299:1161-7.
Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med. 1978;299:1221-7.
Mendez-Sanchez N, Vega H, Uribe M. Risk factors for gallstone disease in Mexicans are similar to those found in Mexican-Americans. Dig Dis Sci. 1998;43:935-9.
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368:230-9.
Ata N, Kucukazman M, Yavuz B. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25:274-6.
ATP III At-a-glance: Quick Desk Reference. Available at: http://www.nhlbi.nih.gov/ Health- pro/guidelines/current/cholesterol-guidelines/quick-desk reference-html.
Layde PM, Vessey MP, Yeates D. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics. J epidemiol Community Health. 1982;36:274-8.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-81.
Mendez Sanchez N, Chavez-Tapia NC, Uribe M. The role of dietary fats in the pathogenesis of gallstones. Front Biosci. 2003;8:e420-e427.
Mohan V, Rao GHR. Type 2 Diabetes in South Asians. 1st ed. New Delhi: South Asian Society on Atherosclerosis and Thrombosis; 2007.
Prasad DS, Kabir Z, Dash AK, Das BC. Abdominal obesity, an independent cardiovascular Risk factor in Indian subcontinent: A clinico epidemiological evidence summary. J Cardiovascular Dis Res. 2011;2:199-205.
Prasad DS, Kabir Z, Dash AK, Das BC. Childhood cardiovascular risk factors in South Asians: A cause of concern for adult cardiovascular disease epidemic. Ann Pediatr Cardiol. 2011;4:166-71.
Nervi F, Miquel JF, Alvarez M. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol. 2006;45:299-305.
Mendez Sanchez N, Chavez Tapia NC, Motola Kuba D. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11:1653-7.
Archard C, Thiers J. Le virlisme pilaire et son association a l’insuffisance glycolytique (diabe‘te des femmes a barb). Bull Acad Natl Med. 1921;86:51-64.
ATP III At-a-glance: Quick Desk Reference. Available at: http://www.nhlbi.nih.gov/Health- pro/guidelines/current/cholesterol-guidelines/quick-desk reference-html.
Aaron DF, Eduardo CL, Adolfo CV, Andrés RP, Mario E. Journal of Laparoendoscopic and Advanced Surgical Techniques. 2017;27(12):1263-8.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-81.
Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012;18(31):4215-20.
Ahmed JM, Mahmood R, Rana RS, Muhammad TP, Haider J, Siddiqui SS, et al. Metabolic syndrome: an indicator of complicated gall stone disease? Cureus. 2018;10(11):e3659.
Sanchez NM, Aponte JB, Tapia NC, Kuba DM, Lara KS, Radríguez GP, et al. Strong association between gallstones and cardiovascular disease. The Am J Gastroenterol. 2005;100(4):827-30.
Ching Lin I, Yang YW, Wu MF, Yeh YH, Liou JC, Lin YL et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Family Practice. 2014;15:138.
Ata N, Kucukazman M, Yavuz B. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25:274-6.
Nakeeb A, Comuzzie AG, Al-Azzawi H, Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940-8.
Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol. An insulin-resistant state. Diabetes. 1994;43:411-7.
Amigo L, Zanlungo S, Mendoza H, Miquel JF, Nervi F. Risk factors and pathogenesis of cholesterol gallstones: state of the art. Eur Rev Med Pharmacol Sci. 1999;3:241-6.
